Castle Biosciences Inc financial data

Symbol
CSTL on Nasdaq
Location
505 S Friendswood Drive, Suite 401, Friendswood, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 734 % -4.56%
Quick Ratio 16.6 % -10.2%
Debt-to-equity 17.7 % +15.1%
Return On Equity -2.69 % -284%
Return On Assets -2.29 % -280%
Operating Margin -10.2 % -2957%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29.2M shares +4.22%
Common Stock, Shares, Outstanding 29.2M shares +4.24%
Entity Public Float 587M USD +88.7%
Weighted Average Number of Shares Outstanding, Basic 29.1M shares +4.43%
Weighted Average Number of Shares Outstanding, Diluted 29.1M shares -1.12%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 344M USD +10.1%
Cost of Revenue 68.9M USD +22.1%
Research and Development Expense 50.1M USD -5.92%
Operating Income (Loss) -34.9M USD -3265%
Income Tax Expense (Benefit) -6.68M USD -232%
Net Income (Loss) Attributable to Parent -12.2M USD -301%
Earnings Per Share, Basic 0 USD/shares -278%
Earnings Per Share, Diluted 0 USD/shares -305%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 85.6M USD -9.9%
Marketable Securities, Current 202M USD
Accounts Receivable, after Allowance for Credit Loss, Current 49.5M USD -1.55%
Inventory, Net 8.65M USD +31.6%
Assets, Current 358M USD +3.71%
Property, Plant and Equipment, Net 22.3M USD +70.6%
Operating Lease, Right-of-Use Asset 15.2M USD +27.3%
Goodwill 10.7M USD 0%
Other Assets, Noncurrent 1.28M USD -30%
Assets 563M USD +9.37%
Accounts Payable, Current 12.2M USD +79.3%
Employee-related Liabilities, Current 31.8M USD +14.8%
Liabilities, Current 55.3M USD +24.9%
Deferred Income Tax Liabilities, Net 3.24M USD -23.2%
Operating Lease, Liability, Noncurrent 25.3M USD +72.2%
Other Liabilities, Noncurrent 16K USD -70.9%
Liabilities 95.7M USD +30.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 240K USD -49.3%
Retained Earnings (Accumulated Deficit) -222M USD -5.84%
Stockholders' Equity Attributable to Parent 467M USD +5.89%
Liabilities and Equity 563M USD +9.37%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.04M USD +11.7%
Net Cash Provided by (Used in) Financing Activities -1.55M USD -115%
Net Cash Provided by (Used in) Investing Activities -22.4M USD -13.9%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 29.2M shares +4.24%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -30M USD -88.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 85.6M USD -9.9%
Deferred Tax Assets, Valuation Allowance 50.5M USD -8.16%
Deferred Tax Assets, Gross 73.2M USD -7.9%
Operating Lease, Liability 16M USD +4.57%
Depreciation 5.86M USD +32.7%
Payments to Acquire Property, Plant, and Equipment 4.74M USD -48.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12.5M USD -288%
Lessee, Operating Lease, Liability, to be Paid 22.8M USD -6.39%
Operating Lease, Liability, Current 1.45M USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.4M USD +6.58%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.95M USD +26.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -770K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.75M USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.44M USD +9.26%
Deferred Tax Assets, Operating Loss Carryforwards 31.8M USD -32.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.49M USD +1.51%
Additional Paid in Capital 689M USD +5.91%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 36.9M USD +308%
Depreciation, Depletion and Amortization 29.8M USD +791%
Deferred Tax Assets, Net of Valuation Allowance 22.7M USD -7.32%
Share-based Payment Arrangement, Expense 45.9M USD -9.39%
Interest Expense 9K USD -95.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%